Diploma (LON:DPLM) Price Target Raised to GBX 6,400 at Deutsche Bank Aktiengesellschaft

Diploma (LON:DPLM) had its target price raised by Deutsche Bank Aktiengesellschaft from GBX 6,200 to GBX 6,400 in a report released on Thursday morning, Marketbeat.com reports. They currently have a buy rating on the stock.

DPLM has been the subject of a number of other research reports. Royal Bank Of Canada boosted their price target on Diploma from GBX 6,200 to GBX 6,600 and gave the company an “outperform” rating in a research note on Thursday. Shore Capital Group reissued a “hold” rating on shares of Diploma in a report on Wednesday. Stifel Nicolaus boosted their target price on shares of Diploma from GBX 6,200 to GBX 6,800 and gave the company a “buy” rating in a research report on Thursday. Berenberg Bank reaffirmed a “buy” rating and set a GBX 6,350 price target on shares of Diploma in a report on Wednesday, November 19th. Finally, Peel Hunt reaffirmed a “buy” rating and set a GBX 6,150 price target on shares of Diploma in a report on Friday, December 19th. Five research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Diploma currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 6,023.75.

Diploma Stock Performance

LON:DPLM opened at GBX 5,795 on Thursday. The company has a market cap of £7.77 billion, a price-to-earnings ratio of 42.21, a PEG ratio of 2.82 and a beta of 1.03. Diploma has a fifty-two week low of GBX 3,532 and a fifty-two week high of GBX 6,019.52. The company has a debt-to-equity ratio of 46.97, a quick ratio of 0.80 and a current ratio of 2.04. The stock has a fifty day moving average price of GBX 5,456.45 and a 200-day moving average price of GBX 5,423.86.

Insider Activity at Diploma

In other Diploma news, insider Ian El-Mokadem bought 500 shares of the stock in a transaction on Wednesday, January 14th. The stock was purchased at an average price of GBX 5,615 per share, with a total value of £28,075. Also, insider Katie Bickerstaffe bought 352 shares of the company’s stock in a transaction dated Wednesday, January 14th. The stock was bought at an average cost of GBX 5,645 per share, with a total value of £19,870.40. 1.14% of the stock is currently owned by insiders.

Trending Headlines about Diploma

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Diploma upgraded full‑year guidance after a stronger‑than‑expected first half, citing resilient aerospace demand — this is the catalyst that drove the recent rally. Article Title Article Title
• Positive Sentiment: Berenberg raised its price target to GBX 7,500 and moved to a “buy” rating, signaling stronger analyst conviction. Article Title
• Positive Sentiment: Stifel Nicolaus lifted its target to GBX 6,800 and reiterated a “buy” stance, reflecting upgraded earnings assumptions. Article Title
• Positive Sentiment: RBC increased its target to GBX 6,600 and moved to “outperform” after Diploma’s guidance upgrade; coverage note posted to LSE and TickerReport. Article Title Article Title
• Positive Sentiment: Deutsche Bank raised its target to GBX 6,400 and set a “buy” rating, further supporting the upgraded consensus view. Article Title
• Neutral Sentiment: Shore Capital reaffirmed a “hold” rating — a reminder some brokers remain cautious despite upgrades. Article Title Article Title
• Neutral Sentiment: Valuation sits elevated after the rally (P/E ~42, PEG ~2.8) and the stock is near its 1‑year high — this raises the bar for further upside absent continued operational beats.
• Negative Sentiment: Despite the positive fundamentals and multiple target lifts, the stock is pulling back mid‑day on very heavy volume — likely short‑term profit‑taking and consolidation after the recent surge.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.